TAS2R43 Antibody

What is TAS2R43 and why is it significant in research?

TAS2R43 is a G-protein coupled receptor belonging to the bitter taste receptor family. It functions as a gustducin-coupled receptor implicated in the perception of bitter compounds in both the oral cavity and gastrointestinal tract. Physiologically, TAS2R43 signals through phospholipase C beta 2 (PLCB2) and the calcium-regulated cation channel TRPM5 .

The significance of TAS2R43 extends beyond taste perception to multiple physiological systems:

• Airway function: In epithelial cells, binding of bitter compounds to TAS2R43 increases intracellular calcium concentration and stimulates ciliary beat frequency, potentially helping to eliminate noxious agents .

• Immune response: Recent research indicates TAS2R43 plays roles in regulating innate immune responses in the intestine .

• Toxin detection: TAS2R43 variants affect responses to aristolochic acid, a carcinogenic contaminant found in some food supplies .

Research with TAS2R43 antibodies enables investigations into these diverse functions across multiple tissue types.

What are the structural characteristics of TAS2R43?

TAS2R43 is a membrane protein with:

• Molecular weight of approximately 35 kDa

• 309 amino acid residues in its canonical form

• Post-translational modifications including glycosylation

• UniProt ID: P59537

• Gene ID: 259289

The protein is sometimes known by alternative names including T2R43, T2R52, taste receptor type 2 member 43, and taste receptor type 2 member 52 .

What types of TAS2R43 antibodies are commercially available?

Most commercially available TAS2R43 antibodies are rabbit polyclonal antibodies that recognize human TAS2R43. Key characteristics include:

How should researchers validate a TAS2R43 antibody for their specific application?

Proper validation of TAS2R43 antibodies requires a systematic approach:

• Positive and negative control selection:

  • Positive controls: Use cell lines known to express TAS2R43 (e.g., COLO205 cells have been validated)

  • Negative controls: Use either knockout/knockdown systems or cell lines lacking TAS2R43 expression

• Cross-reactivity assessment:

  • Some TAS2R43 antibodies cross-react with other TAS2R family members (TAS2R44, TAS2R46, TAS2R47 and TAS2R49)

  • Test specificity using recombinant proteins or cell lines expressing related taste receptors

• Validation across applications:

  • Western blot: Confirm single band at expected molecular weight (35 kDa)

  • Immunofluorescence: Compare staining pattern with expected cellular localization

  • ELISA: Generate standard curves using recombinant TAS2R43

• Genomic considerations:

  • Account for TAS2R43 polymorphisms in your experimental population

  • The gene harbors numerous nonsynonymous variants that may affect antibody binding

What are the recommended protocols for TAS2R43 detection in Western blot?

For optimal Western blot detection of TAS2R43:

• Sample preparation:

  • Use RIPA buffer supplemented with protease inhibitors

  • For membrane proteins like TAS2R43, avoid excessive heating (keep at 70°C for 10 minutes)

• Dilution optimization:

  • Recommended dilutions vary by manufacturer:

    • 1:500-1:1000

    • 1:1000-3000

    • 1:500-1:2000

  • Optimize by testing serial dilutions on positive control samples

• Detection system:

  • Secondary antibody: Anti-rabbit IgG conjugated with HRP

  • Enhanced chemiluminescence (ECL) detection system

• Protocol specifics:

  • Protein loading: 20-50 μg total protein

  • Transfer conditions: Use PVDF membranes for optimal binding of hydrophobic proteins

  • Blocking: 5% non-fat milk or BSA in TBST (1 hour at room temperature)

  • Primary antibody incubation: Overnight at 4°C

  • Secondary antibody incubation: 1 hour at room temperature

How should researchers address the challenge of TAS2R43 polymorphisms in experimental design?

TAS2R43 exhibits significant genetic diversity across populations, with variations that may affect antibody binding and experimental outcomes:

• Polymorphism assessment:

  • The TAS2R43 gene contains 32 segregating sites on average, with nonsynonymous variants particularly common

  • Global population genetics studies have identified 494 nonsynonymous SNPs across the TAS2R family with 169 variants likely to affect receptor function

• Experimental controls:

  • Genotype experimental samples for key nonsynonymous variants

  • Include multiple control samples representing different genetic backgrounds

  • Consider using epitope-tagged constructs for consistent detection

• Epitope selection considerations:

  • Choose antibodies raised against conserved regions of TAS2R43

  • Some antibodies target AA 135-163, 114-163, or 124-173

  • Check whether the epitope region contains known polymorphisms in your study population

• Interpretation guidelines:

  • Document genetic variation when reporting experimental results

  • Consider how polymorphisms might affect protein expression, stability, or antibody recognition

  • For heterogeneous populations, stratify results by genotype

How can TAS2R43 antibodies be used to study receptor function in non-taste tissues?

TAS2R43 has emerging roles beyond taste perception, particularly in:

• Airway epithelial function:

  • Use immunofluorescence with TAS2R43 antibodies to examine receptor localization

  • Combine with calcium imaging to correlate receptor expression with functional responses

  • Protocol: Use 1:100-1:500 dilution for immunofluorescence applications

• Intestinal immune regulation:

  • Recent findings show TAS2R43 regulates innate immune responses to bacterial compounds

  • Co-immunoprecipitation using TAS2R43 antibodies can identify binding partners in signaling pathways

  • Combine with RNA-Seq to identify downstream transcriptional effects

• Tissue-specific expression profiling:

  • Use immunohistochemistry to map receptor distribution across tissues

  • Compare expression levels between normal and diseased states

  • Protocol adaptation: For tissues with potential cross-reactivity, include peptide competition assays

• Functional implications:

  • In intestinal cells, TAS2R43 affects bacterial growth responses to compounds like aloin and quinine

  • TAS2R43 deletion polymorphisms influence the release of mucus glycoprotein CLCA1

  • These findings suggest roles in host-microbiome interactions and mucosal defense

What innovative techniques can be used with TAS2R43 antibodies beyond standard immunoassays?

Researchers can leverage TAS2R43 antibodies in several advanced applications:

• Proximity ligation assays (PLA):

  • Detects protein-protein interactions in situ

  • Can identify TAS2R43 interactions with downstream signaling partners (e.g., PLCB2, TRPM5)

  • Requires combining TAS2R43 antibody with antibodies against potential interaction partners

• Single-cell analysis:

  • Mass cytometry (CyTOF) incorporating TAS2R43 antibodies conjugated to metal isotopes

  • Single-cell proteomics to correlate TAS2R43 expression with other cellular markers

  • Enables identification of TAS2R43-expressing subpopulations in heterogeneous tissues

• Super-resolution microscopy:

  • Techniques like STORM or PALM using fluorophore-conjugated TAS2R43 antibodies

  • Can resolve subcellular localization beyond diffraction limit

  • Useful for studying receptor clustering and membrane microdomains

• Biosensor development:

  • Immobilize TAS2R43 antibodies on sensor surfaces for detection of solubilized receptor

  • Applications in monitoring receptor shedding or release in biological fluids

  • Can be adapted to high-throughput screening platforms

How do genetic variants of TAS2R43 affect antibody selection and experimental outcomes?

The extensive genetic diversity in TAS2R43 creates important considerations:

• Population genetics context:

  • Heterozygosity (π) for TAS2R43 ranges from 0.02% to 0.36% with a mean of 0.12%

  • FST values range from 0.01 to 0.26 with a mean of 0.13, indicating modest differentiation among populations

  • These variations can affect antibody epitope recognition

• Functional implications:

  • Variants in TAS2R43 affect responses to specific compounds:

    • Aristolochic acid (a carcinogenic contaminant)

    • Aloin and quinine (affecting bacterial growth)

  • These variants may modify protein conformation or epitope accessibility

• Epitope mapping strategy:

  • Use multiple antibodies targeting different regions of TAS2R43

  • Perform genotyping alongside antibody-based detection

  • Consider computational prediction of variant effects on protein structure

• Experimental design adaptation:

  • Include controls representing relevant genetic variants

  • Document subject/sample genotypes when reporting results

  • Consider how variants might affect subcellular localization or expression levels

What are common issues when working with TAS2R43 antibodies and how can they be resolved?

Researchers commonly encounter several challenges:

• Cross-reactivity with related receptors:

  • Issue: TAS2R43 shares sequence homology with other TAS2R family members

  • Solution: Use peptide competition assays to confirm specificity

  • Some antibodies explicitly cross-react with TAS2R44, TAS2R46, TAS2R47, and TAS2R49

• Membrane protein solubilization:

  • Issue: As a membrane protein, TAS2R43 can be difficult to extract and may form aggregates

  • Solution: Optimize detergent conditions (try CHAPS, DDM, or Triton X-100)

  • Include reducing agents to prevent disulfide bond formation

• Low expression levels:

  • Issue: Native expression may be below detection threshold in some tissues

  • Solution: Use signal amplification methods such as tyramide signal amplification (TSA)

  • Consider enrichment by immunoprecipitation before Western blot

• Antibody storage issues:

  • Issue: Loss of activity due to improper storage

  • Solution: Store as recommended (typically at -20°C)

  • Aliquot to minimize freeze/thaw cycles

  • Add carrier protein (BSA) for diluted antibody stability

How can researchers optimize detection of TAS2R43 in tissues with low expression levels?

For tissues with limited TAS2R43 expression:

• Sample enrichment strategies:

  • Membrane fraction isolation to concentrate transmembrane proteins

  • Immunoprecipitation before Western blot analysis

  • mRNA analysis (RT-PCR) alongside protein detection to confirm expression

• Signal amplification techniques:

  • Tyramide signal amplification for immunohistochemistry

  • Highly sensitive chemiluminescent substrates for Western blot

  • Quantum dot-conjugated secondary antibodies for fluorescence applications

• Optimized protocols:

  • Extended primary antibody incubation (48-72 hours at 4°C)

  • Reduced washing stringency (lower salt concentration)

  • Use of detergent-free blocking solutions to preserve epitope accessibility

• Alternative detection methods:

  • Proximity ligation assay (PLA) for in situ protein detection

  • Droplet digital PCR for precise quantification of low-abundance transcripts

  • Mass spectrometry following immunoprecipitation

What emerging applications of TAS2R43 antibodies are appearing in recent literature?

Recent research suggests several promising directions:

• Gut-brain axis studies:

  • TAS2R43 in enteroendocrine cells may influence hormone secretion and satiety signaling

  • Antibodies enable mapping of receptor distribution along the gastrointestinal tract

  • Potential implications for appetite regulation and metabolic disorders

• Microbiome interactions:

  • Evidence suggests TAS2R43 mediates responses to bacterial compounds

  • May be involved in monitoring quorum sensing in intestinal flora

  • Antibodies can help identify cell populations responsible for these interactions

• Respiratory disease research:

  • TAS2R43 in airway epithelial cells responds to inhaled compounds

  • May influence ciliary beat frequency and mucus secretion

  • Potential therapeutic target for respiratory conditions

• Personalized medicine applications:

  • Given the extensive genetic variation in TAS2R43 , antibodies can help correlate genotype with protein expression

  • May identify individuals likely to respond to bitter taste receptor-targeting therapeutics

  • Prognostic applications in conditions affected by TAS2R43 variants

How might methodological advances improve TAS2R43 antibody applications?

Emerging technologies offer new possibilities:

• Single-domain antibodies (nanobodies):

  • Smaller size allows better access to epitopes in complex tissues

  • Potential for improved specificity for TAS2R43 variants

  • Can be genetically encoded for in vivo studies

• CRISPR-based validation:

  • Precise genome editing to create knockout controls for antibody validation

  • Introduction of tagged endogenous TAS2R43 for antibody-independent detection

  • Creation of isogenic cell lines differing only in TAS2R43 variants

• Spatial transcriptomics integration:

  • Combining antibody detection with spatial mapping of gene expression

  • Correlating protein localization with transcriptional responses

  • Single-cell resolution of TAS2R43 function in complex tissues

• Computational antibody design:

  • Structure-based design of antibodies targeting conserved regions of TAS2R43

  • Development of variant-specific antibodies for genotype-phenotype studies

  • In silico prediction of epitope accessibility in native membrane environments